ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 93 filers reported holding ADMA BIOLOGICS INC in Q2 2021. The put-call ratio across all filers is 5.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,442 | +20.0% | 402,717 | +23.6% | 0.01% | +40.0% |
| Q2 2023 | $1,202 | +771.0% | 325,769 | +814.3% | 0.01% | +400.0% |
| Q4 2022 | $138 | -99.9% | 35,632 | -30.8% | 0.00% | 0.0% |
| Q3 2022 | $125,000 | -5.3% | 51,489 | -22.7% | 0.00% | 0.0% |
| Q2 2022 | $132,000 | -89.7% | 66,598 | -90.5% | 0.00% | -87.5% |
| Q1 2022 | $1,287,000 | +4051.6% | 703,151 | +3067.6% | 0.02% | – |
| Q4 2021 | $31,000 | -20.5% | 22,198 | -36.0% | 0.00% | -100.0% |
| Q3 2021 | $39,000 | -76.1% | 34,697 | -62.4% | 0.00% | -50.0% |
| Q1 2021 | $163,000 | -14.2% | 92,360 | -5.4% | 0.00% | 0.0% |
| Q4 2020 | $190,000 | -4.5% | 97,656 | +43.5% | 0.00% | -60.0% |
| Q2 2020 | $199,000 | -33.0% | 68,050 | -34.1% | 0.01% | -68.8% |
| Q1 2020 | $297,000 | +403.4% | 103,213 | +566.7% | 0.02% | +300.0% |
| Q1 2019 | $59,000 | – | 15,482 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |